Edition:
India

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

1,543.60INR
25 Sep 2020
Change (% chg)

Rs-2.20 (-0.14%)
Prev Close
Rs1,545.80
Open
Rs1,550.10
Day's High
Rs1,573.20
Day's Low
Rs1,540.00
Volume
57,963
Avg. Vol
83,364
52-wk High
Rs1,807.50
52-wk Low
Rs962.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2021 Jun 6,485.90 6.540
FY 2020 Mar '20 7,758.01 8.138
Dec 7,785.90 -38.031
Sep 8,820.20 29.680
Jun 7,879.70 6.700
FY 2019 Mar '19 7,508.09 8.659
Dec 8,253.50 6.710
Sep 8,163.10 5.950
Jun 7,356.50 4.960
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-20 1 8,097.00 8,097.00 8,097.00 --
Quarter Ending Mar-20 4 7,921.00 8,359.00 7,200.00 --
Year Ending Mar-20 6 32,713.80 34,221.00 32,056.00 --
Year Ending Mar-21 5 33,500.00 34,391.00 32,283.00 38,820.00
Year Ending Mar-22 5 37,067.40 38,172.00 35,551.00 --
Earnings (per share)
Quarter Ending Mar-20 1 7.70 7.70 7.70 --
Year Ending Mar-20 6 27.28 29.80 24.30 --
Year Ending Mar-21 5 30.69 33.10 27.57 33.53
Year Ending Mar-22 5 35.90 37.70 33.32 --
LT Growth Rate (%) 1 33.32 33.32 33.32 --
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 62.45 31.14 33.53
P/E High - Last 5 Yrs. -- 40.50 45.20
P/E Low - Last 5 Yrs. -- 23.86 24.26
Beta 0.17 0.91 0.90
Price to Sales (TTM) 14.01 3.99 5.69
Price to Book (MRQ) -- 4.97 5.07
Price to Tangible Book (MRQ) -- 5.74 6.50
Price to Cash Flow (TTM) 174.34 23.03 23.51
% Owned Institutions -- 0.87 1.73

Dividends

  Company industry sector
Dividend Yield 1.24 1.55 1.49
Dividend Yield - 5 Year Avg -- 1.56 1.51
Dividend 5 Year Growth Rate -- 4.28 5.14
Payout Ratio(TTM) 0.00 45.75 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.37 10.57
Sales (TTM) vs TTM 1 Yr. Ago -- 4.65 5.71
Sales - 5 Yr. Growth Rate -- 9.86 10.05
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 16.29 20.17
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.77
Capital Spending - 5 Yr. Growth Rate -- 15.10 14.97

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.33
Current Ratio (MRQ) -- 3.05 3.16
LT Debt to Equity (MRQ) -- 8.79 11.31
Total Debt to Equity (MRQ) -- 12.59 15.51
Interest Coverage (TTM) -- 41.12 36.66

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 23.80 54.55 54.39
Gross Margin - 5 Yr. Avg. -- 52.05 52.27
EBITD Margin (TTM) 29.85 -- --
EBITD - 5 Yr. Avg -- 18.46 11.96
Operating Margin (TTM) 33.89 14.38 5.41
Operating Margin - 5 Yr. Avg. -- 14.55 7.51
Pre-Tax Margin (TTM) 33.89 14.90 6.29
Pre-Tax Margin - 5 Yr. Avg. -- 14.98 8.02
Net Profit Margin (TTM) 23.12 11.09 2.52
Net Profit Margin - 5 Yr. Avg. -- 11.22 4.24
Effective Tax Rate (TTM) 31.77 23.42 23.33
Effective Tax Rate - 5 Yr. Avg. -- 23.64 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,109,462 978,598,613 879,042,975
Net Income/Employee (TTM) 718,922 116,081,974 104,231,326
Receivable Turnover (TTM) -- 5.78 5.98
Inventory Turnover (TTM) -- 2.66 3.45
Asset Turnover (TTM) -- 0.98 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.90 11.45
Return on Assets - 5 Yr. Avg. -- 13.16 12.56
Return on Investment (TTM) -- 15.42 14.93
Return on Investment - 5 Yr. Avg. -- 17.10 16.29
Return on Equity (TTM) -- 16.77 16.49
Return on Equity - 5 Yr. Avg. -- 18.03 17.40
  1 Year 3 Year 5 Year
Sales % 5.71 -- --
EPS (TTM) % -10.46 -- --
Dividend % -40.00 -- --
Note: Units in Millions of US Dollars

Performance for GlaxoSmithKline Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.25 -2.64 99 21
13 Week -6.52 -7.86 99 38
26 Week -11.71 -17.56 99 34
52 Week -17.27 -26.91 99 13
YTD -11.53 -25.96 99 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.48%
# of Holders: 26
Total Shares Held: 19,452,116
3 Mo. Net Change: -206,080
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 2
# Reduced Positions: 10
# Net Buyers: -8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.